long covid

  1. Chandelier

    Health-related quality of life in IBD patients with long COVID under China’s normalized COVID-19 management, 2026, Wang et al.

    Health-related quality of life in IBD patients with long COVID under China’s normalized COVID-19 management Abstract Introduction Although the COVID pandemic has gradually subsided, many patients have experienced complicated long-term symptoms, collectively known as “long-COVID”, which is...
  2. Chandelier

    Risk factors of post-COVID-19 symptoms, a cross-sectional study in patients with asthma and chronic obstructive lung disease, 2026, Andreason et al.

    Risk factors of post-COVID-19 symptoms, a cross-sectional study in patients with asthma and chronic obstructive lung disease Abstract Post-COVID-19 symptoms are common following COVID-19, but risk factors of persistent symptoms in patients with asthma and chronic obstructive lung disease...
  3. forestglip

    The securitization of global slow-onset risks/threats: long COVID, a case study, 2026, Finkelstein

    The securitization of global slow-onset risks/threats: long COVID, a case study Finkelstein, Philip Abstract This paper investigates why Long Covid, despite affecting millions globally and posing a serious threat to public health and economic stability, remains largely absent from contemporary...
  4. Chandelier

    Brain-binding auto-antibodies in subjects with and without post-COVID-syndrome after SARS-CoV-2 infection, 2026, Faraj et al.

    Brain-binding auto-antibodies in subjects with and without post-COVID-syndrome after SARS-CoV-2 infection Highlights Seroprevalence of brain binding autoantibodies is increased in the long-term after COVID-19 Post COVID Syndrome does not correlate with the prevalence of NMDAR1 autoantibodies...
  5. Chandelier

    Preprint Worsening pre-existing health conditions in U.S. adults with Long COVID, 2026, Edwards et al.

    Worsening pre-existing health conditions in U.S. adults with Long COVID Abstract Purpose Long COVID literature often describes new-onset symptoms or conditions following SARS-CoV-2 infection; however, Long COVID also encompasses the exacerbation of pre-existing conditions. We describe health...
  6. Chandelier

    Preprint Shared Clinical and Immunological Features of Post-Acute COVID-19 and Post-Acute COVID-19 Vaccination Syndromes, 2026, Dinser et al.

    Shared Clinical and Immunological Features of Post-Acute COVID-19 and Post-Acute COVID-19 Vaccination Syndromes Abstract Background Post-acute COVID-19 syndrome (PACS) can cause persistent disability involving fatigue, post-exertional malaise, neurocognitive symptoms, and autonomic...
  7. Chandelier

    Co-Designing an Online Narrative-Based Intervention for Breathing and Psychological Wellbeing for Adolescents With Post-COVID Syndrome, 2026, Wells+

    Co-Designing an Online Narrative-Based Intervention for Breathing and Psychological Wellbeing for Adolescents With Post-COVID Syndrome Abstract Purpose Post-COVID syndrome (PCS) also known as long COVID affects up to 66.5% of children and young people (CYP) following SARS-CoV-2 infection...
  8. Chandelier

    Opinion Long covid and other wise investments of time and money, 2026, Kamran Abbasi

    Long covid and other wise investments of time and money Abbasi, Kamran 2026 and arguments over the covid-19 pandemic continue. If you imagined, as I did, that the deep scientific divisions would be healed with time and by public inquiries, you’d be wrong. Even the tense political divide over...
  9. Chandelier

    Depressive and anxiety symptoms in individuals with Long-COVID: Does social network matter? – Results of a…, 2026, Gerhards, Büchner, Schomerus et al.

    Depressive and anxiety symptoms in individuals with Long-COVID: Does social network matter? – Results of a German Long-COVID study Highlights Living with others was linked to fewer depressive symptoms in adults with Long COVID A larger social network was associated with lower anxiety...
  10. Chandelier

    [GER] “Ultimately, you are on your own.” A qualitative analysis of barriers to health care from the perspective of patients with LC, 2025, Hammer+

    „Im Endeffekt ist man auf sich allein gestellt.“ Eine qualitative Analyse von Versorgungsbarrieren aus der Sicht Long-COVID-Betroffener Abstract Background About 5% of the population are affected by post-infectious symptoms after a Sars-CoV-2-infection. Long COVID or a post-COVID-19 condition...
  11. forestglip

    Hair cortisol concentration and basal heart rate variability differentiate long COVID from depressive disorders in youth, 2026, Oehlke et al

    Hair cortisol concentration and basal heart rate variability differentiate long COVID from depressive disorders in youth Oehlke, S.-M.; Lozar, A.; Goreis, A.; Klinger, D.; Nater, U.M.; Skoluda, N.; Binder, H.; Plener, P.L.; Kothgassner, O.D. Highlights • Despite clinical overlap, long...
  12. forestglip

    Review A dual-database bibliometric analysis of post-COVID-19 condition and cognitive dysfunction (2021–2025), 2026, Pu et al

    A dual-database bibliometric analysis of post-COVID-19 condition and cognitive dysfunction (2021–2025) Pu, Junlin; Chen, Wenjie; Jiang, Hangcheng; Yang, Hong Background Coronavirus disease 2019 (COVID-19), caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)...
  13. Chandelier

    Placental trophoblasts exhibit iron dysregulation and ferroptosis signaling associated with SARS-CoV-2 restriction, 2026, McColl et al.

    Placental trophoblasts exhibit iron dysregulation and ferroptosis signaling associated with SARS-CoV-2 restriction Highlights • Active SARS-CoV-2 infection impairs placental iron efflux and activates ferroptosis • Activation of ferroptosis inhibits SARS-CoV-2 replication in trophoblasts •...
  14. Chandelier

    Role of Ferroptosis in the Progression of COVID-19 and the Development of Long COVID, 2025, Zhao et al.

    Role of Ferroptosis in the Progression of COVID-19 and the Development of Long COVID Abstract Objective: This study aimed to examine the role of ferroptosis on the pathogenesis and progression of COVID-19. Materials and Methods: A total of 127 patients who were hospitalized for COVID-19 were...
  15. Chandelier

    Long COVID shows IL-1 pathway dysregulation without a discrete circulating biomarker signature, 2026, Muñoz-López et al.

    Long COVID shows IL-1 pathway dysregulation without a discrete circulating biomarker signature Abstract Long COVID (LC) is characterized by persistent and, often, disabling symptoms, yet its biological basis remains unclear. Multiple mechanisms, including immune dysregulation, endothelial...
  16. Chandelier

    Research Program: BioSig-PEM – Identification of Biopathological Signatures of Post-Exertional Malaise in ME/CFS, 2027, Puta, Ramoji, Aden, Seifert+

    https://www.gesundheitsforschung-bmftr.de/de/biosig-pem-identifizierung-biopathologischer-signaturen-von-post-exertional-malaise-bei-me-18111.php Google Translate link. Machine Translation: BioSig-PEM – Identification of Biopathological Signatures of Post-Exertional Malaise in ME/CFS Myalgic...
  17. Chandelier

    Protocol Synergy of Wearable Data Systems for Post COVID (SynoSys.PC), 2028, Puta, Brockmann et al.

    There doesn't seem to be a clinical trial registration protocol. Here's what I could find via other sources: Machine Translation: Synergy of Wearable Data Systems for Post COVID (SynoSys.PC) Departmental research in the field of “Healthcare Provision,” cross-cutting topic “Long/Post COVID,”...
  18. Chandelier

    Evidence for positive long- and short-term effects of vaccinations against COVID-19 in wearable sensor metrics, 2023, Wiedermann, Brockmann et al.

    Evidence for positive long- and short-term effects of vaccinations against COVID-19 in wearable sensor metrics Abstract Vaccines are among the most powerful tools to combat the COVID-19 pandemic. They are highly effective against infection and substantially reduce the risk of severe disease...
  19. Chandelier

    ACE2-like Catalytic Activity in Anti-SARS-CoV-2 Spike Protein Monoclonal Antibodies, 2026, Song et al.

    ACE2-like Catalytic Activity in Anti-SARS-CoV-2 Spike Protein Monoclonal Antibodies Abstract Many people are affected by difficult-to-understand clinical phenomena associated with acute SARS-CoV-2 infection and by post-acute sequelae of COVID-19 (PASC, or long COVID, LC). The mechanisms...
  20. Chandelier

    Structured, expert-informed selection and harmonization of patient-reported outcome measures (PROMs) …: the [LC] use case, 2026, Hanc, Löwe, Köllner+

    Structured, expert-informed selection and harmonization of patient-reported outcome measures (PROMs) in a German multicenter network: the post-COVID syndrome use case Abstract Background Patient-reported outcome measures (PROMs) provide subjective information on symptoms, functional ability...
Back
Top Bottom